Berenberg raises Sartorius target to EUR 280.00: Sartorius stock falls 2.01 percent
Published on 10/05/2026 at 12:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sartorius stock (ISIN DE0007165631) was trading at EUR 246.75 at Lang & Schwarz on October 5, 2026 at 12:07 p.m. CEST, down 2.01 percent versus the prior close of EUR 251.80. MarketScreener reported that Berenberg raised its target from EUR 270.00 to EUR 280.00 on September 11, 2026 and kept a Buy rating.
Berenberg sees a EUR 280.00 target
The target increase gives Sartorius a fresh analyst benchmark while the stock remains EUR 33.25 below that level. Measured against the EUR 280.00 target, the Lang & Schwarz price stood 11.88 percent below it on October 5, 2026.
The same MarketScreener page identifies Sartorius as a supplier of pharmaceutical and laboratory equipment with bioprocess solutions and lab products and services as its two operating segments.
Revenue missed second-quarter consensus
Sartorius reported revenue of EUR 911.80 million in the second quarter of 2026, below the EUR 934.20 million consensus estimate, according to Parqet. The EUR 22.40 million gap puts the analyst target increase alongside a clear execution test for the next report.
Parqet lists adjusted earnings per share of EUR 1.29 for the second quarter against consensus of EUR 1.36. The next report is scheduled for October 22, 2026, giving investors a defined checkpoint for revenue and earnings revisions.
Fiscal 2026 guidance sets the test
On its investor-relations page, Sartorius guides to constant-currency sales growth of 5 to 9 percent for fiscal 2026. Management also expects the underlying EBITDA margin to move above 30 percent, compared with 29.7 percent in fiscal 2025.
The guidance range matters because the second-quarter revenue result fell EUR 22.40 million short of consensus, while the analyst target assumes recovery in demand. The combination leaves the October report as the next major numerical test for the investment case.
Stock trades below the prior close
The EUR 246.75 price is 13.25 percent above the 52-week low of EUR 198.50 and 8.61 percent below the 52-week high of EUR 270.00, based on the October 5, 2026 market snapshot. Sartorius carried a market capitalization of EUR 17.1 billion on the same date.
The further course of trading is shown by the continuously updated real-time quote of Sartorius stock.
Sartorius stock facts
- Company: Sartorius AG
- ISIN: DE0007165631
- WKN: 716563
- Ticker: SRT3
- Primary exchange: Xetra
- Price Lang & Schwarz as of October 5, 2026 at 12:07 p.m. CEST: EUR 246.75
- Change versus prior close: minus 2.01 percent
- Prior close Lang & Schwarz October 2, 2026: EUR 251.80
- Market capitalization: EUR 17.1 billion as of October 5, 2026
- 52-week range: EUR 198.50-270.00 as of October 5, 2026
- Sector / Industry: Healthcare / Advanced Medical Equipment and Technology
- Next earnings date: October 22, 2026
